000			02073cam a2200349 a 4500
003			EG-GiCUC
005			20250223031131.0
008			150112s2014 ua h f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.01.M.Sc.2014.Ab.C
100	0		_aAbdelrazek Ahmed Abdelrazek
245	1	0	_aComparative study for the effect of bupivacaine Vs bupivacaine plus dexmedetomidine as analgesia in nasal surgeries / _cAbdelrazek Ahmed Abdelrazek ; Supervised Mohamed Said Osman , Eman Ahmed Foad , Marwa Said Zayed
246	1	5	_aدراسة مقارنة بين تأثير عقار البيوبيفاكين و عقار البيوبيفاكين بالإضافة إلى عقار الديكسوميتوميدين فى علاج الألم فى عمليات الأنف
260			_aCairo : _bAbdelrazek Ahmed Abdelrazek , _c2014
300			_a68 Leaves : _bfacsimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Anaesthesia
520			_aLocal anesthetics are used to induce anesthesia and analgesia for surgical procedures and for pain management. Complications of local anesthesia may range from localized reactions such as edema, urticaria and dermatitis to systemic absorption resulting in severe cardiovascular collapse and neurological toxicity. Continuous monitoring of the patient is mandatory when using local anesthetics. There are many guidelines for prevention and management of local anesthetic toxicity. Dexmedetomidine is the most recent Ü 2-adrenoceptor agonist approved by FDA in 1999 for use in humans for analgesia and sedation
530			_aIssued also as CD
653		4	_aBupivacaine
653		4	_aDexmedetomidine
653		4	_aSeptoplasty
700	0		_aEman Ahmed Foad , _eSupervisor
700	0		_aMarwa Said Zayed , _eSupervisor
700	0		_aMohamed Said Osman , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c49073 _d49073